Spectrum Pharmaceuticals Inc. [NASDAQ: SPPI] traded at a high on 04/25/23, posting a 32.66 gain after which it closed the day’ session at $0.92. The company report on April 25, 2023 at 6:00 AM that Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in All Stock and CVR Transaction.
Complementary Commercial Growth Platforms Anticipated to Accelerate ROLVEDON™ (eflapegrastim-xnst) Injection Profitability and Diversify Revenue Streams.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Combination of Assertio’s Omni-Channel Digital Sales Capabilities and ROLVEDON In-Person Commercial Team to Enhance Market Access and Growth across All Products.
The results of the trading session contributed to over 34132416 shares changing hands. Over the past one week, the price volatility of Spectrum Pharmaceuticals Inc. stands at 6.75% while the volatility over the past one month is 6.18%.
The market cap for SPPI stock reached $186.47 million, with 199.49 million shares outstanding and 184.03 million shares in the current float. Compared to the average trading volume of 1.64M shares, SPPI reached a trading volume of 34132416 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Spectrum Pharmaceuticals Inc. [SPPI]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SPPI shares is $2.65 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SPPI stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JMP Securities have made an estimate for Spectrum Pharmaceuticals Inc. shares, keeping their opinion on the stock as Mkt Outperform, with their previous recommendation back on September 17, 2020. The new note on the price target was released on December 26, 2019, representing the official price target for Spectrum Pharmaceuticals Inc. stock. Previously, the target price had yet another drop from $17 to $4, while Cantor Fitzgerald kept a Neutral rating on SPPI stock.
The Average True Range (ATR) for Spectrum Pharmaceuticals Inc. is set at 0.06, with the Price to Sales ratio for SPPI stock in the period of the last 12 months amounting to 18.46. The Price to Book ratio for the last quarter was 6.54, with the Price to Cash per share for the same quarter was set at 0.37.
How has SPPI stock performed recently?
Spectrum Pharmaceuticals Inc. [SPPI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 28.29. With this latest performance, SPPI shares gained by 36.72% in over the last four-week period, additionally plugging by 134.87% over the last 6 months – not to mention a drop of -11.07% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SPPI stock in for the last two-week period is set at 69.15, with the RSI for the last a single of trading hit 78.55, and the three-weeks RSI is set at 63.33 for Spectrum Pharmaceuticals Inc. [SPPI]. The present Moving Average for the last 50 days of trading for this stock 0.7745, while it was recorded at 0.7389 for the last single week of trading, and 0.7091 for the last 200 days.
Spectrum Pharmaceuticals Inc. [SPPI]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Spectrum Pharmaceuticals Inc. [SPPI] shares currently have an operating margin of -718.78 and a Gross Margin at +82.28. Spectrum Pharmaceuticals Inc.’s Net Margin is presently recorded at -772.24.
Return on Equity for this stock declined to -207.06, with Return on Assets sitting at -72.69.
Spectrum Pharmaceuticals Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.20 and a Current Ratio set at 2.40.
Insider trade positions for Spectrum Pharmaceuticals Inc. [SPPI]
There are presently around $32 million, or 26.30% of SPPI stock, in the hands of institutional investors. The top three institutional holders of SPPI stocks are: ARMISTICE CAPITAL, LLC with ownership of 17,000,000, which is approximately 1.943% of the company’s market cap and around 1.60% of the total institutional ownership; VANGUARD GROUP INC, holding 8,400,287 shares of the stock with an approximate value of $5.8 million in SPPI stocks shares; and BLACKROCK INC., currently with $2.68 million in SPPI stock with ownership of nearly -46.328% of the company’s market capitalization.
Positions in Spectrum Pharmaceuticals Inc. stocks held by institutional investors increased at the end of Thursday and at the time of the Thursday reporting period, where 23 institutional holders increased their position in Spectrum Pharmaceuticals Inc. [NASDAQ:SPPI] by around 3,449,612 shares. Additionally, 36 investors decreased positions by around 10,316,067 shares, while 23 investors held positions by with 31,970,651 shares. The mentioned changes placed institutional holdings at 45,736,330 shares, according to the latest SEC report filing. SPPI stock had 7 new institutional investments in for a total of 341,198 shares, while 12 institutional investors sold positions of 1,126,627 shares during the same period.